However, this previous ESCC studies using EpCAM-based CTC isolation strategy may underestimate the highly heterogeneous CTC population, and might miss those aggressive refractory CTCs undergoing EMT or CTCs, with cancer stemness properties [8,17]. The gene discussed is EPCAM; the disease is cancer.